Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults

University of Chicago · NCT06395415

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–26 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
46
US sites recruiting
1
Study start
April 25, 2025
Record last updated
April 27, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Electronic Nicotine Delivery Systems (ENDS) use remains prevalent among young adults, and many have high interest in quitting, yet research on effective intervention is lacking. A mobile health (mHealth) intervention that translates effective smoking cessation materials and pharmacotherapy may be a promising avenue for intervention. The initial phase of the proposed study uses a pilot study to evaluate a novel mHealth intervention for young adult ENDS and dual product (ENDS and combustible cigarette) users.

Being studied: EQUIP; Standard Care

Conditions: Electronic Nicotine Delivery Systems; Tobacco Products; Cigarette Smoking

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Age 18-26 years old, ability to understand the English language, willing and able to provide informed consent
  • Current ENDS user (at least 4 out of 7 days per week of use for the past one month); for focus groups, at least half of participants will report current cigarette smoking (at least 1 cigarette per day on at least 1 day per week in the past month)
  • Report interest in quitting or reducing ENDS (at least 6/10 scale in interest of quitting or reducing
  • Does not currently (in past one year) meet criteria for major psychiatric disorder including severe alcohol or substance use disorder (excluding tobacco use disorder), schizophrenia, bipolar disorder, and obsessive compulsive disorder
  • For women, not currently pregnant, planning to become pregnant, or breastfeeding due to lack of information on ENDS use and possible harms from NRT during pregnancy
  • Not currently using smoking cessation medication (i.e., Varenicline, Bupropion
  • No history of adverse reactions to nicotine replacement therapy

Exclusion Criteria

  • Does not own a mobile phone or is unwilling to receive text messages to their device
  • No interest in quitting or reducing use of ENDS
  • Uses electronic cigarettes less than 4 days per week in the past month
  • Reports past-year serious psychiatric illness, including severe alcohol or substance use disorder (excluding tobacco use disorder), schizophrenia, bipolar disorder, and obsessive compulsive disorder
  • Is currently using smoking cessation medication including Varenicline or Bupropion
  • Are a female who is currently pregnant or nursing or planning to become pregnant within the next 6 months

Recruiting US locations

  • University of Chicago BREATHE Laboratory

    Chicago, IL 60637

    Site contact: Emma Dr. Brett · 773-834-5341 · ebrett@bsd.uchicago.edu

Study contacts (from the official record)

  • Emma Brett, PhD · 773-834-5341 · ebrett@bsd.uchicago.edu
All smoking & vaping studies in Illinois →
Development of a Mobile Health Intervention for Electronic… (NCT06395415) | Bored Studies